Innovating Works
GATBIO NEXT: GATBIO NEXT: advancing GRT's 1st oral biologic - GB-AF-004 - to clinical demonstration and out-licen... GAT BIOSCIENCES tramitó un HORIZON EUROPE: HORIZON-EIE-2022-SCALEUP-02-02 GAT Biosciences (GATBIO) is a women-led Biotech SME targeting the exploitation of its proprietary GRTTM technology as a novel solution for t...
2023-05-31 - 2024-05-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.